Citations (59)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Jun Tao, Chenglin Ye, Wen Dai, Di Li, Man Zhou & Yan Li. (2021) Serum Level of Complement C1q is Associated with Contrast-Associated Acute Kidney Injury in Patients Undergoing Emergency Percutaneous Coronary Intervention. Journal of Inflammation Research 14, pages 7331-7339.
Read now
Read now
Michael Kirschfink & Tom Eirik Mollnes. (2001) C1-inhibitor: an anti-inflammatory reagent with therapeutic potential. Expert Opinion on Pharmacotherapy 2:7, pages 1073-1083.
Read now
Read now
Articles from other publishers (57)
Mads Lamm Larsen, Anne Troldborg, Erik J M Toonen, Lisa Hurler, Zoltan Prohaszka, László Cervenak, Annette Gudmann Hansen & Steffen Thiel. (2023) Differentiating between activation via the lectin or the classical complement pathway in patients with systemic lupus erythematosus. Clinical and Experimental Immunology 214:1, pages 18-25.
Crossref
Crossref
Désirée Tampe, Samy Hakroush & Björn Tampe. (2022)
Molecular signatures of intrarenal complement receptors
C3AR1
and
C5AR1
correlate with renal outcome in human lupus nephritis
. Lupus Science & Medicine 9:1, pages e000831.
Crossref
Crossref
Desiree Tampe, Samy Hakroush & Björn Tampe. (2022) Dissecting signalling pathways associated with intrarenal synthesis of complement components in lupus nephritis. RMD Open 8:2, pages e002517.
Crossref
Crossref
ABHIGYAN Satyam, RYO HISADA, RHEA BHARGAVA, MARIA G. TSOKOS & GEORGE C. TSOKOS. (2022) Intertwined pathways of complement activation command the pathogenesis of lupus nephritis. Translational Research 245, pages 18-29.
Crossref
Crossref
Qianqian Ma, Jingyun Luan, Yu Bai, Caili Xu, Fangyu Liu, Bufeng Chen, Dianwen Ju & Hong Xu. (2022) Interleukin-22 in Renal Protection and Its Pathological Role in Kidney Diseases. Frontiers in Immunology 13.
Crossref
Crossref
María Galindo-Izquierdo & José Luis Pablos Alvarez. (2021) Complement as a Therapeutic Target in Systemic Autoimmune Diseases. Cells 10:1, pages 148.
Crossref
Crossref
Marieke Sternkopf, Sven Thoröe-Boveleth, Tobias Beck, Kirsten Oleschko, Ansgar Erlenkötter, Ulrich Tschulena, Sonja Steppan, Thimoteus Speer, Claudia Goettsch, Vera Jankowski, Joachim Jankowski & Heidi Noels. (2019) A Bifunctional Adsorber Particle for the Removal of Hydrophobic Uremic Toxins from Whole Blood of Renal Failure Patients. Toxins 11:7, pages 389.
Crossref
Crossref
Jelena Antić-Stanković & Sanja Stanković. (2017) THE COMPLEMENT SYSTEM: PATHWAYS OF ACTIVATIONS AND FUNCTION. Acta medica Medianae 56:1, pages 50-55.
Crossref
Crossref
Lihua Bao, Patrick N. Cunningham & Richard J. Quigg. (2015) Complement in Lupus Nephritis: New Perspectives. Kidney Diseases 1:2, pages 91-99.
Crossref
Crossref
V. Michael Holers. (2008) The spectrum of complement alternative pathway‐mediated diseases. Immunological Reviews 223:1, pages 300-316.
Crossref
Crossref
Douglas J. Weiss. (2007) Acute bone marrow stromal injury in the dog. Comparative Clinical Pathology 16:4, pages 223-228.
Crossref
Crossref
Lihua Bao & Richard J. Quigg. (2007) Complement in Lupus Nephritis: The Good, the Bad, and the Unknown. Seminars in Nephrology 27:1, pages 69-80.
Crossref
Crossref
Dana V. Devine. 2007. Blood Banking and Transfusion Medicine. Blood Banking and Transfusion Medicine
30
42
.
Christopher C. Silliman & Michael Wang. (2006) The merits of in vitro versus in vivo modeling in investigation of the immune system. Environmental Toxicology and Pharmacology 21:2, pages 123-134.
Crossref
Crossref
Lihua Bao, Iyabo Osawe, Mark Haas & Richard J. Quigg. (2005) Signaling through Up-Regulated C3a Receptor Is Key to the Development of Experimental Lupus Nephritis. The Journal of Immunology 175:3, pages 1947-1955.
Crossref
Crossref
Lihua Bao, Iyabo Osawe, Tipu Puri, John D. Lambris, Mark Haas & Richard J. Quigg. (2005) C5a promotes development of experimental lupus nephritis which can be blocked with a specific receptor antagonist. European Journal of Immunology 35:8, pages 2496-2506.
Crossref
Crossref
Edward N. Janoff & Jeffrey B. Rubins. 2004. The Pneumococcus. The Pneumococcus
252
280
.
V.Michael Holers. (2003) The complement system as a therapeutic target in autoimmunity. Clinical Immunology 107:3, pages 140-151.
Crossref
Crossref
James Martin, Everett Magann & Christy Isler. 2002. Hypertension in Pregnancy. Hypertension in Pregnancy
141
188
.
Lihua Bao, Mark Haas, Susan A. Boackle, Damian M. Kraus, Patrick N. Cunningham, Pierce Park, Jessy J. Alexander, Randall K. Anderson, Kristin Culhane, V. Michael Holers & Richard J. Quigg. (2002)
Transgenic Expression of a Soluble Complement Inhibitor Protects Against Renal Disease and Promotes Survival in MRL/
lpr
Mice
. The Journal of Immunology 168:7, pages 3601-3607.
Crossref
Crossref
E Zimmermann-Nielsen, S.E Svehag, O Thorlacius-Ussing & G Baatrup. (2001) ELISA for evaluating the incorporation of plasma derived complement split-products C3b/iC3b into solid-phase immune complexes. Journal of Immunological Methods 249:1-2, pages 43-51.
Crossref
Crossref
B. Paul Morgan. 2001. Physiology of Inflammation. Physiology of Inflammation
131
145
.
Agustin P. Dalmasso. 2000. Xenotransplantation. Xenotransplantation
53
83
.
V.Michael Holers. (2000) Phenotypes of complement knockouts. Immunopharmacology 49:1-2, pages 125-131.
Crossref
Crossref
Katrin Jurianz & Michael Kirschfink. 2000. Multiple Organ Failure. Multiple Organ Failure
214
223
.
Hao Wang, Scott A. Rollins, Zuhua Gao, Bertha Garcia, Zheng Zhang, Jingjing Xing, Lan Li, Richard Kellersmann, Louis A. Matis & Robert Zhong. (1999) COMPLEMENT INHIBITION WITH AN ANTI-C5 MONOCLONAL ANTIBODY PREVENTS HYPERACUTE REJECTION IN A XENOGRAFT HEART TRANSPLANTATION MODEL1. Transplantation 68:11, pages 1643-1651.
Crossref
Crossref
Delphine Logeart-Avramoglou & Jacqueline Jozefonvicz. (1999) Carboxymethyl benzylamide sulfonate dextrans (CMDBS), a family of biospecific polymers endowed with numerous biological properties: A review. Journal of Biomedical Materials Research 48:4, pages 578-590.
Crossref
Crossref
BENGTSSON, REDL, SCHLAG, HÖGÅSEN, GÖTZE & MOLLNES. (1998) Anti-TNF Treatment of Baboons with Sepsis Reduces TNF-α, IL-6 and IL-8, but not the Degree of Complement Activation. Scandinavian Journal of Immunology 48:5, pages 509-514.
Crossref
Crossref
Richard J. Quigg, Chun He, Alice Lim, Dawn Berthiaume, Jessy J. Alexander, Damian Kraus & V. Michael Holers. (1998) Transgenic Mice Overexpressing the Complement Inhibitor Crry as a Soluble Protein Are Protected from Antibody-induced Glomerular Injury. The Journal of Experimental Medicine 188:7, pages 1321-1331.
Crossref
Crossref
Jeffrey W. Kronson, Bernhard J. Hering, David E.R. Sutherland, Yasuki Tanioka, John P. Leone, Nicole Kirchhof & Agustin P. Dalmasso. (1998) POSTTRANSPLANT NONFUNCTION OF CANINE ISLETS IN PVG RATS DEFICIENT IN COMPLEMENT COMPONENT C61. Transplantation 65:12, pages 1549-1554.
Crossref
Crossref
Michael Kirschfink. (1997) Controlling the complement system in inflammation. Immunopharmacology 38:1-2, pages 51-62.
Crossref
Crossref
Eugen P Zilow, Wolfgang Hauck, Otwin Linderkamp & Gertrud Zilow. (1997) Alternative Pathway Activation of the Complement System in Preterm Infants with Early Onset Infection. Pediatric Research 41:3, pages 334-339.
Crossref
Crossref
Anna Petrova, Tatjana Gnedko, Irene Maistrova, Marina Zafranskaya & Nicholas Dainiak. (2009) Morbidity in a large cohort study of children born to mothers exposed to radiation from chernobyl. STEM CELLS 15:S1, pages 141-150.
Crossref
Crossref
A. P. Dalmasso. 1997. Xenotransplantation. Xenotransplantation
38
60
.
R.N. Kalaria, M. Harshbarger-Kelly, D.L. Cohen & D.R.D. Premkumar. (1996) Molecular aspects of inflammatory and immune responses in Alzheimer's disease. Neurobiology of Aging 17:5, pages 687-693.
Crossref
Crossref
A E AhmedJ B Peter. (1995) Clinical utility of complement assessment. Clinical Diagnostic Laboratory Immunology 2:5, pages 509-517.
Crossref
Crossref
Shizunori Ichida, Yukio Yuzawa, Hidechika Okada, Kazuo Yoshioka & Seiichi Matsuo. (1994) Localization of the complement regulatory proteins in the normal human kidney. Kidney International 46:1, pages 89-96.
Crossref
Crossref
Magnus Haeger & Anders Bengtsson. (2008) Humoral immunology in normotensive and hypertensive pregnancy. Fetal and Maternal Medicine Review 6:2, pages 95-112.
Crossref
Crossref
M. Haeger. (1993) The role of complement in pregnancy-induced hypertensive disease. International Journal of Gynecology & Obstetrics 43:2, pages 113-127.
Crossref
Crossref
Thomas J. Lang & Moon L. Shin. (1993) Activation of the alternative complement pathway and production of Factor H by skeletal myotubes. Journal of Neuroimmunology 44:2, pages 185-192.
Crossref
Crossref
A. Bengtsson, H. Redl & G. Schlag. 1993. Pathophysiology of Shock, Sepsis, and Organ Failure. Pathophysiology of Shock, Sepsis, and Organ Failure
447
458
.
M. Heideman & A. Bengtsson. 1993. Pathophysiology of Shock, Sepsis, and Organ Failure. Pathophysiology of Shock, Sepsis, and Organ Failure
25
35
.
Jose Manuel Porcel & Diego Vergani. (2016) Review: Complement and Lupus: Old Concepts and New Directions. Lupus 1:6, pages 343-349.
Crossref
Crossref
R. Brian Stevens & Jeffrey L. Platt. (1992) The Pathogenesis of Hyperacute Xenograft Rejection. American Journal of Kidney Diseases 20:4, pages 414-421.
Crossref
Crossref
Agustin P. Dalmasso. (1992) The complement system in xenotransplantation. Immunopharmacology 24:2, pages 149-160.
Crossref
Crossref
Edward N. Janoff, Robert F. Breiman, Charles L. Daley & Philip C. Hopewell. (1992) Pneumococcal Disease during HIV Infection. Annals of Internal Medicine 117:4, pages 314-324.
Crossref
Crossref
Lee A. Hebert, Fernando G. Cosio & John C. Neff. (1991) Diagnostic significance of hypocomplementemia. Kidney International 39:5, pages 811-821.
Crossref
Crossref
Robert J. Wyatt, Bruce A. Julian & Marian L. Rivas. (1991) Role for Specific Complement Phenotypes and Deficiencies in the Clinical Expression of IgA Nephropathy. The American Journal of the Medical Sciences 301:2, pages 115-123.
Crossref
Crossref
Harvey A. Schenkein. (2016) The Role of Complement in Periodontal Diseases. Critical Reviews in Oral Biology & Medicine 2:1, pages 65-81.
Crossref
Crossref
J. L. Platt & F. H. Bach. 1991. Xenotransplantation. Xenotransplantation
69
79
.
A. BENGTSSON, J.‐P. BENGTSON, Å. RYDENHAG, L. ROXVALL & M. HEIDEMAN. (2009) Accumulation of anaphylatoxins and terminal complement complexes in inflammatory fluids. Journal of Internal Medicine 228:2, pages 173-176.
Crossref
Crossref
R. Burger. 1990. Immunotherapeutic Prospects of Infectious Diseases. Immunotherapeutic Prospects of Infectious Diseases
163
172
.
Leopoldo Raij, Agustin P. Dalmasso, Nancy A. Staley & Alfred J. Fish. (1989) Renal injury in DOCA-salt hypertensive C5-sufficient and C5-deficient mice. Kidney International 36:4, pages 582-592.
Crossref
Crossref
E. Metzmann. 1989. Analytiker-Taschenbuch. Analytiker-Taschenbuch
179
198
.
Fred Wiener, Torgny Groth & Ulf Nilsson. (1989) A knowledge-based system for automatic interpretation of an analytical profile of complement factors. Journal of Clinical Laboratory Analysis 3:5, pages 287-295.
Crossref
Crossref
Robert J. Wyatt & Bruce A. Julian. (1988) Activation of Complement in IgA Nephropathy. American Journal of Kidney Diseases 12:5, pages 437-442.
Crossref
Crossref
H. -U. Schulz, G. Letko, H. -J. Hass, H. Spormann, P. Kemnitz, P. Burger & U. Wendt. (1988) Effects of pancreatic acinar cell surface antibodies and complement on isolated rat acinar cells in vitro. Virchows Archiv B Cell Pathology 55:1.
Crossref
Crossref